Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Actinium Pharmaceuticals

Clinical trials sponsored by Actinium Pharmaceuticals, explained in plain language.

Actinium Pharmaceuticals ATNM NYSE AMERICAN

A biopharmaceutical company developing targeted radiotherapies for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1

Radioactive antibody could boost stem cell transplant success in tough leukemia

Disease control Not yet recruiting

This study tests a new approach for people with relapsed or refractory acute myeloid leukemia (AML) who have active disease. Before a stem cell transplant, patients receive a radioactive antibody (131I-apamistamab) along with chemotherapy and low-dose radiation to prepare the bod…

Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control

Last updated Jun 26, 2026 16:44 UTC